Brief: Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia
25/06/2025 13:45
June 25 (Reuters) - Intelligent Bio Solutions Inc INBS.O: INTELLIGENT BIO SOLUTIONS AND SPJOTGARD DRIVE RAPID ADOPTION OF FINGERPRINT DRUG TESTING ACROSS SCANDINAVIA Source text: ID:nGNX6pvYWS Further company coverage: INBS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelligent Bio Solutions
See all newsBrief: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth
Brief: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry
Intelligent Bio Solutions Q3 revenue rises 46%, gross margin tops 50%
Intelligent Bio Solutions rise after clearing security tests ahead of FDA filing
Brief: Intelligent Bio Solutions Completes Clinical Cut-Off Study